R
Roland E. Schmieder
Researcher at University of Erlangen-Nuremberg
Publications - 780
Citations - 85811
Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.
Papers
More filters
Journal ArticleDOI
The Fcγ receptor IIA R131H gene polymorphism is associated with endothelial function in patients with hypercholesterolaemia
Markus P. Schneider,Jeanette H. W. Leusen,Martin Herrmann,Christoph D. Garlichs,Kerstin Amann,Stefan John,Roland E. Schmieder +6 more
TL;DR: The functional effects of the FcγRIIa H131R gene polymorphism previously observed in vitro translate into clinically relevant alterations of endothelial function in vivo and are suggested to be associated with impaired EDV and reduced NO activity during endothelial cell stimulation.
Journal ArticleDOI
Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial
Kazuomi Kario,Michael A. Weber,Michael Böhm,Raymond R. Townsend,Felix Mahfoud,Roland E. Schmieder,Konstantinos Tsioufis,Sidney Cohen,Martin Fahy,David E. Kandzari +9 more
TL;DR: RDN appears effective in attenuating the slope of morning surge in DBP that might indicate possible benefits in a high-risk hypertensive population, as reported in several randomized sham-controlled trials.
Journal ArticleDOI
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Emanuele Barbato,Michel Azizi,Roland E. Schmieder,Lucas Lauder,Michael Böhm,Sofie Brouwers,Rosa Maria Bruno,Dariusz Dudek,Thomas Kahan,David E. Kandzari,Thomas F. Lüscher,Gianfranco Parati,Atul Pathak,Flavio Ribichini,Markus P. Schlaich,Andrew S.P. Sharp,Isabella Sudano,Massimo Volpe,Costas Tsioufis,William Wijns,Felix Mahfoud +20 more
TL;DR: In this article , the authors proposed that renal denervation (RDN) is an adjunct treatment option in uncontrolled resistant hypertension, confirmed by ambulatory BP measurements, despite best efforts at lifestyle and pharmacological interventions.
Journal ArticleDOI
The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
Christian Ott,Felix Mahfoud,Axel Schmid,Sebastian Ewen,Stefan W. Toennes,Markus R. Meyer,Andreas G. Helfer,Hans H. Maurer,Tilmann Ditting,Roland Veelken,Ina Zivanovic,Michael Uder,Michael Böhm,Roland E. Schmieder +13 more
TL;DR: The data indicate that even after given full respect to drug adherence as potential confounder of BP response after RDN, both office and 24-h ABPM were substantially reduced in patients with moderate TRH.
Journal ArticleDOI
Changes in Stroke Volume After Renal Denervation: Insight From Cardiac Magnetic Resonance Imaging.
Philip Lurz,Karl-Patrik Kresoja,Karl-Philipp Rommel,Maximilian von Roeder,Christian Besler,Christian Lücke,Matthias Gutberlet,Roland E. Schmieder,Felix Mahfoud,Holger Thiele,Steffen Desch,Karl Fengler +11 more
TL;DR: In this paper, the effects of catheter-based renal denervation (RDN) on cardiac function in patients with hypertension undergoing RDN and compared with sham treatment were evaluated.